Search
Filter Results
- Resource Type
- Book2
- Article1
- Book Digital1
- Book Print1
- Article Type
- Case Reports1
- Result From
- Lane Catalog1
- PubMed1
- SearchWorks (biomedical subset) 1
-
Year
- Journal Title
- Stomatologiia (Mosk)1
Search Results
Sort by
- Bookedited by Andrew Teasdale, AstraZeneca, London, United Kingdom, David Elder, Consultant (fGSK), Hertford, Hertfordshire, SG14 2DE, United Kingdom, Raymond W. Nims, RMC Pharmaceutical Solutions, Inc., Longmont, CO, USA.Summary: "Examining the implications and practical implementation of multi-disciplinary International Conference on Harmonization (ICH) topics, this book gives an integrated view of how the guidelines inform drug development strategic planning and decision-making. Addresses a consistent need for interpretation, training, and implementation examples of ICH guidelines via case studies. Offers a primary reference point for practitioners addressing the dual challenge of interpretation and practical implementation of ICH guidelines. Uses case studies to help readers understand and apply ICH guidelines. Provides valuable insights into guidelines development, with chapters by authors involved in generating or with experience implementing the guidelines. Includes coverage of stability testing, analytical method validation, impurities, biotechnology drugs and products, and good manufacturing practice (GMP)"-- Provided by publisher.
Contents:
An Introduction to ICH Quality Guidelines
ICHQ1A(R2) Stability Testing of New Drug Substance and Product and ICHQ1C Stability Testing of New Dosage Forms / Andy Rignall
Stability Testing / David Clapham
ICH Q1D / Raymond Peter Munden
ICH Q1E Evaluation for Stability Data / Garry Scrivens
Q2(R1) Validation of Analytical Procedures / Phillip Borman, David Elder
Impurities in New Drug Substances and New Drug Products / Andrew Teasdale, David Elder, James Harvey, Steven Spanhaak
ICH Q3C Impurities / John Connelly
ICH Q3D Elemental Impurities / Andrew Teasdale, Sarah Thompson
ICH Q4 / David Elder
ICH Q5A / Daniel Galbraith
ICH Q5B Analysis of the Expression Construct in Cell Lines Used for Production of Recombinant DNA-Derived Protein Products / Jianxin Ye, Zhong Liu, David Pollard
ICH Q5C Stability Testing of Biotechnological/Biological Products / John G Davies, Di Gao, Yoen Joo Kim, Richard Harris, Patricia W Cash, Timothy L Schofield, Roujian Zhang, Qiang Qin
Q5D Derivation and Characterization of Cell Substrates Used for Production of Biotechnological/Biological Products / Mark Plavsic
Conduct of Risk Assessments / Raymond W Nims
ICH Q5E Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Processes / Ramani R Raghavan, Robert McCombie
ICH Q6A Specifications / David Elder
ICH Q6B Specifications / Scott R Rudge, Raymond W Nims
Process-Related Impurities in Biopharmaceuticals / Anil Raghani, Kim Li, Jeanine L Bussiere, Joel P Bercu, Jinshu Qiu
ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (APIs) / Gordon Munro
Q8(R2) / Per Holm, Morten Allesø, Mette C Bryder, René Holm
ICH Q9 Quality Risk Management / David Elder, Andrew Teasdale
ICH Q10 Quality Systems / Larry Wigman, Danny Ooi
ICH Q11 / Ronald Ogilvie
ICH M7 / Andrew Teasdale.Digital Access Wiley 2018 - ArticleRybalov OV, Dolgina LM.Stomatologiia (Mosk). 1977 Nov-Dec;56(6):77.